DarioHealth (DRIO) Expected to Announce Quarterly Earnings on Wednesday

DarioHealth (NASDAQ:DRIO) is expected to be releasing its Q1 2025 earnings data before the market opens on Wednesday, May 14th. Analysts expect DarioHealth to post earnings of ($0.07) per share and revenue of $7.48 million for the quarter.

DarioHealth Stock Performance

Shares of DRIO opened at $0.76 on Tuesday. The company has a market cap of $31.59 million, a PE ratio of -0.81 and a beta of 1.55. The company has a current ratio of 1.57, a quick ratio of 1.32 and a debt-to-equity ratio of 0.35. The stock has a 50-day moving average price of $0.68 and a 200-day moving average price of $0.73. DarioHealth has a 12-month low of $0.50 and a 12-month high of $1.93.

Wall Street Analysts Forecast Growth

A number of equities analysts have commented on the company. TD Cowen cut DarioHealth from a “buy” rating to a “hold” rating and decreased their price target for the stock from $2.00 to $1.00 in a research note on Wednesday, January 29th. Stifel Nicolaus decreased their price target on DarioHealth from $3.50 to $2.00 and set a “buy” rating on the stock in a research note on Tuesday, March 11th.

DarioHealth Company Profile

DarioHealth Corp. operates as a digital health company in the United States, Canada, the European Union, Australia, and New Zealand. Its digital therapeutics platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health.